VB-10.16

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameVB-10.16

Drug Alias NameVB-10.16VB10.16

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsUterine Cervical NeoplasmsOropharyngeal NeoplasmsSquamous Cell Carcinoma of Head and Neck +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCzechiaBelgiumBulgaria +[10]

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesNykode Therapeutics AS Cobra Biologics

China Registration ClassN/A

Develop Information

Active CompaniesNykode Therapeutics ASA Nykode Therapeutics AS

Inactive CompaniesN/A

Active IndicationsUterine Cervical NeoplasmsOropharyngeal NeoplasmsSquamous Cell Carcinoma of Head and Neck

Inactive IndicationsCervical Intraepithelial NeoplasiaNeoplasms

Other Information

ATC CodeN/A